Catalyst Wire Dossier Catalyst Wire Dossier

Bevonescein

Bevonescein · Alume Biosciences, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Bevonescein, covering 2024-10-28 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Bevonescein for Intra-Operative Nerve Visualization in Head and Neck Surgery [Phase 3]

See pricing